查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1950526

週边血管栓塞系统市场（依产品类型、材料、技术、线圈尺寸、适应症、最终用户和分销管道划分），全球预测，2026-2032年

Peripheral Coil Embolization System Market by Product Type, Material, Technology, Coil Size, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025 年外周线圈栓塞系统市场价值为 2.1963 亿美元，预计 2026 年将成长至 2.2745 亿美元，预计到 2032 年将达到 3.4591 亿美元，复合年增长率为 6.70%。

关键市场统计数据
基准年 2025 2.1963亿美元
预计年份：2026年 2.2745亿美元
预测年份 2032 3.4591亿美元
复合年增长率 (%) 6.70%

週边血管栓塞术融合了介入放射学、神经外科和血管内治疗。这类装置在现代临床实践中发挥着至关重要的作用，可用于闭塞病变血管、稳定动脉瘤以及治疗各种血管畸形。过去十年间，临床技术和装置设计同步发展。影像导引和导管技术的进步提高了手术精度，而线圈几何形状和材料成分的改进则提升了栓塞的持久性和操作灵活性。

因此，包括医院、门诊手术中心和专科诊所相关人员在评估器械选择时，不仅考虑即时临床疗效，还考虑输送性、与微导管的兼容性以及长期血管重塑的证据。临床医师越来越倾向选择既能最大限度降低血栓栓塞风险，又能提供良好贴合性和填充密度的弹簧圈。同时，专注于互补技术的创新路径，例如促进组织整合的聚合物涂层和生物活性表面处理，也越来越受到重视。本文为战略决策提供了背景资讯。器械开发商必须使产品创新与不断变化的临床偏好、监管要求以及不同的终端用户实际操作情况相适应。

技术创新、监管调整和临床实践的转变正在重新定义弹簧圈栓塞治疗的治疗路径和医护人员动态。

週边血管栓塞术的格局正因三大相互关联的因素而迅速变化：技术创新、临床实践模式的改变以及监管和报销政策的演变。线圈材料和製造技术的进步，包括水凝胶膨胀技术和聚合物涂层表面，提高了栓塞术的性能上限。这些创新透过提高栓塞密度和降低再通率，直接转化为临床获益，从而改变了临床医师的选择和治疗方案。

评估美国2025年对线圈栓塞术相关人员征收关税的累积经济影响、供应链影响和创新影响

2025年关税的实施为全球医疗设备供应链引入了新的变数，对零件采购、製造地选择和定价策略产生了连锁反应。依赖跨境供应链的医疗器材和零件面临着迫在眉睫的成本压力，迫使製造商权衡利弊：是自行承担额外成本、将其转嫁给买家，还是重新设计筹资策略。对许多供应商而言，最直接的应对措施是加快近岸外包，并深化与位于关税优惠地区的契约製造的合作，从而在保持单位成本优势的同时，维持对熟练产能的利用。

从产品、适应症、最终用户、分销、材料、技术和线圈尺寸等方面识别观点变化，从而指导商业化选择。

了解市场区隔的细微差别对于使产品开发和商业化策略与临床及机构需求保持一致至关重要。根据产品类型，市场参与企业将产品分为可脱卸弹簧圈、纤维弹簧圈、液压弹簧圈和推入式弹簧圈，其中可脱卸弹簧圈又可细分为电解、机械式和气动式脱卸机制。这种产品层面的细分非常重要，因为每种设计都有不同的操作特性和与辅助设备的兼容性。临床应用主要基于适应症，涵盖动静脉畸形、脑动脉瘤治疗、颅内静脉窦血栓症和周边血管畸形，每种适应症都对应不同的手术流程、疗效评估指标和报销机制。

美洲、欧洲、中东和非洲以及亚太地区的区域绩效和机会矩阵重点关注了市场准入、报销和推广应用方面的驱动因素。

区域趋势影响临床应用和商业策略，美洲、欧洲、中东和非洲地区以及亚太地区的驱动因素各不相同。在美洲，成熟的医院基础设施、许多关键意见领袖（KOL）以及完善的医保报销机制促进了先进线圈技术的快速应用。同时，成本控制压力和医保支付方的严格审查也促使人们关注可证实的临床效益和可靠的卫生经济学证据。在欧洲、中东和非洲地区，不同的法规环境和不断变化的医保报销机制意味着不同地区的市场准入情况存在差异。能够适应区域监管协调工作并采取灵活定价策略的製造商往往能够获得更广泛的市场渗透。

公司层面的竞争与合作动态影响整个栓塞生态系中的产品蓝图、临床证据产生与策略联盟。

在栓塞线圈领域，企业层面的发展趋势取决于现有医疗设备产品组合、针对性创新和策略伙伴关係的整合。成熟的医疗设备製造商利用其现有的分销网络和稳固的临床关係来支持新型线圈的上市，而专业製造商和敏捷的Start-Ups公司则通常透过专注于生物活性涂层或新型脱出机制等技术进步来脱颖而出。合作模式日益普遍，成熟企业与专业创新者签订共同开发和授权协议，以加快产品临床应用速度，而契约製造製造商在扩大生产规模和控製成本方面发挥关键作用。

为产业领导者提供切实可行的策略建议，以加速创新、确保供应链韧性、优化市场推广策略并扩大临床应用。

为保持发展动能并抓住新的机会，产业领导者应采取一系列相互关联的策略。首先，应优先考虑供应链韧性，实现零件采购多元化并投资于区域组装能力。这将有助于降低政策主导的成本波动风险，并确保供应的持续性。其次，应加快推进能够证明患者疗效显着改善的临床证据项目，并专注于对支付方和医院采购委员会至关重要的终点指标。高品质的真实世界数据和註册登记数据将有助于医保报销谈判和临床医生采纳相关技术。

为了确保分析的严谨性和对决策的相关性，我们采用稳健的混合调查方法，将主要专家研究与次要证据综合相结合。

本分析所依据的研究采用混合方法，结合了来自关键相关人员的对话、有针对性的二手研究以及严谨的分析综合，对证据进行三角验证。主要投入包括：对介入放射学和神经外科的关键高管进行结构化访谈；与医院和门诊手术中心的采购和供应链高管进行深入讨论；以及咨询製造和监管专家以检验运营假设。这些工作提供了关于设备性能偏好、临床工作流程和采购优先事项的定性见解。

研究结果提供了重要的策略见解，突显了投资重点、商业化重点领域以及相关人员的协作参与，以维持长期成长。

总之，週边血管栓塞术生态系统正处于转折点，其特点是材料创新、手术流程改进和供应链监管加强。结合了更优的生物相互作用、可靠的脱落机制以及与现有手术工具包无缝整合的器械越来越受到临床医生的青睐。同时，政策变化和关税相关的成本压力也凸显了生产灵活性和采购多元化的重要性，并强调了技术卓越与营运韧性并重的必要性。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 週边弹簧圈栓塞系统市场（依产品类型划分）

  • 可拆卸线圈
    • 电解解吸线圈
    • 机械可拆卸线圈
    • 气动可拆卸线圈
  • 光纤线圈
  • 水力线圈
  • 推式线圈

9. 週边弹簧圈栓塞系统市场（依材料划分）

  • 水凝胶线圈
  • 铂金线圈
  • 铂钨线圈

10. 週边线圈栓塞系统市场（依技术划分）

  • 裸露金属线圈
  • 生物活性线圈
  • 聚合物涂层线圈

11. 依线圈尺寸分類的外周线圈栓塞系统市场

  • 大线圈
  • 宏线圈
  • 微线圈

12. 週边血管栓塞系统市场（依适应症划分）

  • 动静脉畸形
  • 脑动脉瘤
  • 颅内静脉窦血栓症
  • 週边血管畸形

13. 週边线圈栓塞系统市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 研究所
  • 专科诊所

14. 週边线圈栓塞系统市场（依分销管道划分）

  • 直销
  • 经销商
  • 线上管道

15. 週边弹簧圈栓塞系统市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

16. 週边弹簧圈栓塞系统市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

17. 各国週边血管栓塞系统市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

18. 美国週边血管栓塞系统市场

19. 中国週边血管栓塞系统市场

第20章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Acandis GmbH & Co. KG
  • AngioDynamics, Inc.
  • Asahi Intecc Co., Ltd.
  • Balt Extrusion SAS
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cordis Corporation
  • EndoShape, Inc.
  • Guerbet SA
  • InspireMD, Inc.
  • Johnson & Johnson
  • Kaneka Corporation
  • Medikit Co., Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Shape Memory Medical Inc.
  • Stryker Corporation
  • Terumo Corporation
  • Vesalio SA
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FD8BD

The Peripheral Coil Embolization System Market was valued at USD 219.63 million in 2025 and is projected to grow to USD 227.45 million in 2026, with a CAGR of 6.70%, reaching USD 345.91 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 219.63 million
Estimated Year [2026] USD 227.45 million
Forecast Year [2032] USD 345.91 million
CAGR (%) 6.70%

The peripheral coil embolization landscape sits at the intersection of interventional radiology, neurosurgery, and endovascular therapy. Devices in this class are integral to contemporary practice for occluding pathological vascular structures, stabilizing aneurysms, and managing a range of vascular malformations. Over the last decade clinical techniques and device engineering have matured in parallel: imaging guidance and catheter technologies have improved procedural precision, while incremental design refinements in coil geometry and material composition have enhanced occlusion durability and handling characteristics.

Consequently, stakeholders across hospitals, ambulatory surgical centers, and specialty clinics now evaluate device choice not only on immediate clinical outcomes but also on deliverability, microcatheter compatibility, and evidence of long-term vessel remodeling. Clinicians increasingly prioritize coils that balance conformability with packing density while minimizing thromboembolic risk. At the same time, innovation pathways emphasize adjunctive technologies such as polymer coatings and bioactive surface treatments to accelerate tissue integration. This introduction establishes a context for strategic decision-making: device developers must align product innovation with evolving clinical preferences, regulatory expectations, and the operational realities of diverse end users.

How technological innovation, regulatory recalibration, and clinical practice shifts are redefining treatment pathways and supplier dynamics in coil embolization

The landscape for peripheral coil embolization is changing rapidly under the influence of three interlinked forces: technological innovation, shifting clinical practice patterns, and an evolving regulatory and reimbursement environment. Advances in coil materials and manufacturing, including hydrogel-enabled expansion technologies and polymer-coated surfaces, have moved the performance ceiling forward. These technical innovations translate directly into clinical benefits by improving packing density and reducing recanalization, which in turn alter operator preference and procedural algorithms.

Clinical practice has also been influenced by enhanced imaging modalities and procedural adjuncts. High-resolution intraprocedural imaging and improved microcatheter designs allow clinicians to access distal anatomies and deploy complex constructs with greater confidence. As a result, indications previously considered high risk are increasingly treatable with endovascular approaches. In parallel, regulatory pathways in several jurisdictions are accelerating access for devices backed by robust clinical evidence and real-world performance data, prompting manufacturers to invest early in pivotal studies and post-market registries. Taken together, these shifts are recalibrating value propositions across the product spectrum, favoring devices that combine proven clinical efficacy with ease of use and predictable supply chain performance.

Assessing the cumulative economic, supply chain, and innovation impacts of the United States tariffs implemented in 2025 on coil embolization stakeholders

The tariff measures enacted in 2025 introduced a new variable into the global medical device supply chain, with cascading effects on component sourcing, manufacturing location decisions, and pricing strategies. Devices and subcomponents that relied on cross-border supply chains experienced immediate cost pressure, prompting manufacturers to evaluate the trade-offs between absorbing incremental costs, passing them to purchasers, or redesigning sourcing strategies. For many suppliers the most expedient response was to accelerate nearshoring and to deepen partnerships with contract manufacturers located in tariff-favored jurisdictions, thereby preserving unit economics while maintaining access to skilled production capacity.

In addition to supply chain reconfiguration, the tariffs have intensified scrutiny on total landed cost and on regulatory compliance workflows for imported components. Providers and procurement teams are responding by instituting longer-term supplier contracts and by requiring greater transparency regarding component provenance and quality management. Importantly, the tariffs have also shifted investment calculus for new product introductions. Manufacturers targeting markets heavily affected by tariffation have prioritized modular designs and local assembly models to reduce exposure to cross-border duties. Looking forward, stakeholders who establish diversified sourcing strategies and who invest in manufacturing agility will be better positioned to mitigate the ongoing policy-driven volatility and to sustain clinical and commercial momentum.

Integrated segmentation perspectives revealing product, indication, end-user, distribution, material, technology, and coil-size dynamics that guide commercialization choices

A nuanced understanding of segmentation is essential for aligning product development and commercialization strategies with clinical and institutional needs. Based on product type, market participants distinguish among detachable coils, fibered coils, HydroCoils, and pushable coils, and within detachable coils there is further differentiation into electrolytic, mechanical, and pneumatic detachable mechanisms. This product-level granularity matters because each design imparts distinct handling characteristics and compatibility profiles with adjunct devices. Based on indication, the clinical focus spans arteriovenous malformations, cerebral aneurysm management, intracranial venous sinus thrombosis, and peripheral vascular malformations, with distinct procedural workflows, outcome metrics, and reimbursement constructs tied to each indication.

Based on end user, adoption dynamics vary across ambulatory surgical centers, hospitals, research institutes, and specialty clinics; each setting imposes different purchasing cycles, inventory practices, and clinical staffing models that influence product selection. Based on distribution channel, manufacturers balance direct sales, distributor relationships, and online channels to reach heterogeneous buyers while optimizing support and training. Based on material, coil choices include hydrogel coils, platinum coils, and platinum-tungsten coils, where material selection affects radiopacity, conformability, and biological interaction. Based on technology, devices are differentiated as bare metal coils, bioactive coils, and polymer-coated coils with implications for healing responses and retreatment rates. Finally, based on coil size, therapeutic approaches segment across large coils, macrocoils, and microcoils, each suited to specific vessel sizes and target anatomies. Together, these segmentation lenses provide a comprehensive framework for prioritizing R&D investments, tailoring clinical education, and calibrating go-to-market strategies.

Regional performance and opportunity matrices across the Americas, Europe Middle East & Africa, and Asia-Pacific highlighting access, reimbursement, and adoption drivers

Regional dynamics shape both clinical adoption and commercial strategy, with differentiated drivers across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, a mature hospital infrastructure, a concentration of key opinion leaders, and established reimbursement pathways support rapid uptake of advanced coil technologies; conversely, cost containment pressures and payer scrutiny incentivize demonstrable clinical benefit and robust health economic evidence. In Europe Middle East & Africa, heterogeneous regulatory environments and variable reimbursement mechanisms create a patchwork of access; manufacturers that align with regional regulatory harmonization efforts and that develop adaptable pricing strategies tend to achieve broader penetration.

In Asia-Pacific, accelerating investments in interventional capacity, expanding procedural volumes, and a growing base of domestic manufacturers are shifting the competitive landscape. Regional stakeholders here emphasize affordability, local regulatory approvals, and training programs to develop operator proficiency. Across all regions, cross-border collaboration on clinical registries and post-market surveillance is becoming a de facto expectation, enabling faster recognition of best practices and facilitating iterative product improvements. For companies expanding geographically, a regionally nuanced approach that balances clinical evidence generation with tailored commercial and support models yields the most durable results.

Competitive and collaborative company-level dynamics shaping product roadmaps, clinical evidence generation, and strategic partnerships across the coil embolization ecosystem

Company-level dynamics in the coil embolization space are defined by a blend of legacy device portfolios, targeted innovation, and strategic partnerships. Incumbent medical device firms leverage existing sales networks and established clinical relationships to support new coil introductions, while specialized manufacturers and agile startups often differentiate through focused technology advancements such as bioactive coatings or novel detachment mechanisms. Collaborative models are increasingly common: larger firms enter co-development or licensing agreements with specialist innovators to accelerate time-to-clinic, and contract manufacturing organizations play a pivotal role in scaling production while enabling cost control.

Clinical data and post-market evidence remain decisive competitive assets, prompting companies to invest in investigator-initiated studies, registries, and real-world evidence programs. Additionally, services that improve procedural efficiency, such as comprehensive training modules and digital tools for case planning, have become differentiators that extend beyond the device itself. For corporate development teams, strategic acquisitions and minority investments are attractive pathways to acquire complementary technologies or to secure intellectual property that addresses procedural pain points. Overall, companies that combine robust clinical evidence generation with flexible supply strategies and integrated customer support are most likely to sustain and extend their market presence.

Actionable strategic recommendations for industry leaders to accelerate innovation, secure resilient supply chains, optimize go-to-market approaches, and expand clinical adoption

Industry leaders should pursue a set of interlocking strategies to maintain momentum and to capture emerging opportunities. First, prioritize supply chain resilience by diversifying component sourcing and investing in regional assembly capabilities; doing so reduces exposure to policy-driven cost shifts and supports continuity of supply. Second, accelerate clinical evidence programs that demonstrate meaningful outcome improvements, focusing on endpoints that resonate with payers and hospital procurement committees. High-quality real-world data and registry participation will support reimbursement dialogues and clinician adoption.

Third, invest in product modularity and compatibility, ensuring new coils integrate smoothly with prevailing microcatheter platforms and imaging workflows; compatibility reduces training friction and shortens adoption cycles. Fourth, enhance value-based propositions through bundled service offerings that include training, case planning, and outcome monitoring, thereby positioning products as part of integrated care pathways rather than as stand-alone devices. Fifth, tailor regional go-to-market approaches by aligning pricing, clinical education, and regulatory engagement to local conditions; this targeted approach accelerates penetration in diverse healthcare landscapes. Finally, pursue strategic partnerships for shared development risks and to access specialized manufacturing or distribution capabilities, ensuring that capital and operational resources are deployed efficiently toward high-impact innovations.

Robust mixed-method research methodology combining primary expert engagement and secondary evidence synthesis to ensure analytical rigor and decision relevance

The research underpinning this analysis relies on a mixed-methods approach designed to triangulate evidence from primary stakeholder engagement, targeted secondary research, and rigorous analytical synthesis. Primary inputs include structured interviews with clinical key opinion leaders across interventional radiology and neurosurgery, in-depth discussions with procurement and supply chain executives in hospitals and ambulatory surgical centers, and consultations with manufacturing and regulatory specialists to validate operational assumptions. These engagements provided qualitative insight into device performance preferences, clinical workflows, and sourcing priorities.

Secondary evidence synthesis drew on peer-reviewed clinical literature, procedural guidelines, regulatory filings, and public corporate disclosures to corroborate primary findings and to map technology trajectories. Data were analyzed through a framework that aligns product attributes with clinical indications, end-user requirements, distribution channel dynamics, material properties, technology type, and coil size. Throughout the process, findings were validated through iterative expert review and scenario testing to ensure robustness and decision relevance. This methodological rigor supports a transparent linkage between observed clinical trends, operational constraints, and strategic implications for stakeholders.

Conclusive strategic takeaways emphasizing priority investments, commercialization focus areas, and coordinated stakeholder engagement to sustain long-term growth

In conclusion, the peripheral coil embolization ecosystem is at an inflection point characterized by material innovation, procedural refinement, and heightened supply chain scrutiny. Devices that combine improved biological interaction, reliable detachment mechanisms, and seamless integration with existing procedural toolkits are increasingly favored by clinicians. At the same time, policy shifts and tariff-related cost pressures have elevated the importance of manufacturing agility and sourcing diversity, underscoring that technical excellence must be matched with operational resilience.

Strategically, manufacturers should commit to evidence-led product introductions, regionally tailored commercialization models, and partnerships that accelerate both clinical validation and scale-up. For healthcare providers and payers, the emphasis will be on demonstrable improvements in clinical outcomes, care efficiency, and total cost of care. Those organizations that proactively align product design, clinical research, and supply chain strategies will be best positioned to translate innovation into sustained clinical and commercial impact.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Peripheral Coil Embolization System Market, by Product Type

  • 8.1. Detachable Coils
    • 8.1.1. Electrolytic Detachable Coils
    • 8.1.2. Mechanical Detachable Coils
    • 8.1.3. Pneumatic Detachable Coils
  • 8.2. Fibered Coils
  • 8.3. HydroCoils
  • 8.4. Pushable Coils

9. Peripheral Coil Embolization System Market, by Material

  • 9.1. Hydrogel Coils
  • 9.2. Platinum Coils
  • 9.3. Platinum-Tungsten Coils

10. Peripheral Coil Embolization System Market, by Technology

  • 10.1. Bare Metal Coils
  • 10.2. Bioactive Coils
  • 10.3. Polymer Coated Coils

11. Peripheral Coil Embolization System Market, by Coil Size

  • 11.1. Large Coils
  • 11.2. Macrocoils
  • 11.3. Microcoils

12. Peripheral Coil Embolization System Market, by Indication

  • 12.1. Arteriovenous Malformations
  • 12.2. Cerebral Aneurysm
  • 12.3. Intracranial Venous Sinus Thrombosis
  • 12.4. Peripheral Vascular Malformations

13. Peripheral Coil Embolization System Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Hospitals
  • 13.3. Research Institutes
  • 13.4. Specialty Clinics

14. Peripheral Coil Embolization System Market, by Distribution Channel

  • 14.1. Direct Sales
  • 14.2. Distributors
  • 14.3. Online Channels

15. Peripheral Coil Embolization System Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Peripheral Coil Embolization System Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Peripheral Coil Embolization System Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Peripheral Coil Embolization System Market

19. China Peripheral Coil Embolization System Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2025
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2025
  • 20.3. Product Portfolio Analysis, 2025
  • 20.4. Benchmarking Analysis, 2025
  • 20.5. Acandis GmbH & Co. KG
  • 20.6. AngioDynamics, Inc.
  • 20.7. Asahi Intecc Co., Ltd.
  • 20.8. Balt Extrusion S.A.S.
  • 20.9. Becton, Dickinson and Company
  • 20.10. Boston Scientific Corporation
  • 20.11. Cardinal Health, Inc.
  • 20.12. Cordis Corporation
  • 20.13. EndoShape, Inc.
  • 20.14. Guerbet S.A.
  • 20.15. InspireMD, Inc.
  • 20.16. Johnson & Johnson
  • 20.17. Kaneka Corporation
  • 20.18. Medikit Co., Ltd.
  • 20.19. Medtronic plc
  • 20.20. Merit Medical Systems, Inc.
  • 20.21. MicroPort Scientific Corporation
  • 20.22. Penumbra, Inc.
  • 20.23. Phenox GmbH
  • 20.24. Shape Memory Medical Inc.
  • 20.25. Stryker Corporation
  • 20.26. Terumo Corporation
  • 20.27. Vesalio SA
  • 20.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ELECTROLYTIC DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MECHANICAL DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PNEUMATIC DETACHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PNEUMATIC DETACHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PNEUMATIC DETACHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FIBERED COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FIBERED COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY FIBERED COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROCOILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROCOILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROCOILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PUSHABLE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PUSHABLE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PUSHABLE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HYDROGEL COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM-TUNGSTEN COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM-TUNGSTEN COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PLATINUM-TUNGSTEN COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE METAL COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE METAL COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BARE METAL COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY BIOACTIVE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYMER COATED COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYMER COATED COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY POLYMER COATED COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY LARGE COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY LARGE COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY LARGE COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MACROCOILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MACROCOILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MACROCOILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROCOILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROCOILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MICROCOILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ARTERIOVENOUS MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY CEREBRAL ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL VENOUS SINUS THROMBOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL VENOUS SINUS THROMBOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INTRACRANIAL VENOUS SINUS THROMBOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL VASCULAR MALFORMATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL VASCULAR MALFORMATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PERIPHERAL VASCULAR MALFORMATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DETACHABLE COILS, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY COIL SIZE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PERIPHERAL COIL EMBOLIZATION SYSTEM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)